The state of the union on treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

The state of the union on treatment of acute myeloid leukemia

Published:2014-03-25 Issue:11 Volume:55 Page:2423-2425
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Emadi Ashkan¹,Karp Judith E.²

Affiliation:

1. Leukemia & Hematologic Malignancies, Marlene & Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA

2. Division of Hematologic Malignancies, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.897705

Reference11 articles.

1. Cancer statistics, 2014

2. Myelodysplastic syndromes

3. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

4. Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program

5. Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of ortho-naphthoquinones as anti-AML agents by highly efficient oxidation of phenols;Bioorganic Chemistry;2019-05

2. Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone – A novel class of compounds with potent activity against acute myeloid leukemia cells;Bioorganic & Medicinal Chemistry Letters;2017-01

3. Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia;Pharmaceuticals;2016-03-10

4. Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2;Pharmaceuticals;2016-01-19

5. Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute;JNCI: Journal of the National Cancer Institute;2015-11-09